rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2010-3-24
|
pubmed:abstractText |
The aim of this study was to investigate the effects of the cytochrome P450 3A4 (CYP34A) inhibitor itraconazole on the pharmacokinetics and pharmacodynamics of orally and intravenously administered oxycodone.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1432-1041
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
387-97
|
pubmed:meshHeading |
pubmed-meshheading:20076952-Analgesics, Opioid,
pubmed-meshheading:20076952-Area Under Curve,
pubmed-meshheading:20076952-Cross-Over Studies,
pubmed-meshheading:20076952-Cytochrome P-450 CYP3A,
pubmed-meshheading:20076952-Humans,
pubmed-meshheading:20076952-Injections, Intravenous,
pubmed-meshheading:20076952-Itraconazole,
pubmed-meshheading:20076952-Morphinans,
pubmed-meshheading:20076952-Oxidation-Reduction,
pubmed-meshheading:20076952-Oxycodone,
pubmed-meshheading:20076952-Oxymorphone
|
pubmed:year |
2010
|
pubmed:articleTitle |
Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone.
|
pubmed:affiliation |
Department of Anesthesiology, University of Turku, Finland. teijo.saari@tyks.fi
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|